The Annex III Club: Why September 29 Is the Real Deadline in Pharma’s Tariff War
Seventeen companies were named first when Washington imposed a 100% tariff on patented drugs and…
Regulatory
CRO Services Market Projected to Reach $175.5 Billion by 2032
The global contract research organization (CRO) services market is poised for significant growth, projected to…
Regulatory Pressure & Supply Shock: Why Europe’s Drug Shortages Became Chronic – and What Everyone’s Missing
“Shortages aren’t accidents; they’re features of how the market is built.” Outside declared emergencies EMA…
Paper Cuts: Dossier Mistakes That Stopped Big Drugs Cold
Introduction: Nothing stings quite like a regulatory refusal in the high-stakes world of drug development.…
505(b)(2): The Fast Track to Innovation in Pharma
Connecting the Past and Future of Drug Development 505(b)(2): Towards the Future, While Reflecting the Past While…